Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test maker Exact Sciences Corp, Bloomberg ...
All adverse outcomes were of mild or moderate severity, and no significant trends were observed on the basis of LVEF status. The most common adverse events were hypotension (33%-36.4%), arrhythmia ...
Money Talks News on MSN
Skip the Colonoscopy: New Study Shows Simple Stool Test Just as Effective
Scientists have discovered that collecting stool samples at home is as life-saving as invasive colonoscopy procedures.
Adding a single dose of linaclotide to polyethylene glycol-based bowel preparation significantly improves adenoma and polyp detection rates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results